Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Large-Scale Clinical Data Confirms Efficacy and Safety of Switch to Vemlidy for Hep B: Gilead
March 9, 2020
- AnGes, Osaka Univ. to Pair Up to Develop DNA Vaccines for COVID-19
March 6, 2020
- Chugai, Teijin Suffer Hefty 9% Cuts in 2020 Drug Price Revision: Jiho Poll
March 6, 2020
- Keytruda Remains Top-Seller in February Drug Ranking: Encise
March 6, 2020
- Takeda Joins Fight against COVID-19, Eyes Plasma Product Launch in 9-18 Months
March 5, 2020
- Braftovi/Mektovi Filed for Colorectal Cancer in Japan: Ono
March 5, 2020
- Takeda Closes Non-Core Asset Divestment to Stada
March 5, 2020
- 1st Patient Dosed Telomelysin Together with Radiotherapy in Japan PII Study for Esophageal Cancer: Chugai
March 5, 2020
- Asahi Kasei Completes Acquisition of Veloxis
March 5, 2020
- Sumitomo Dainippon Creates Chief Scientific Officer Post to Optimize Portfolio
March 4, 2020
- Shionogi’s Fetcroja Bags EU Panel Nod
March 4, 2020
- Sawai Refrains from Sales Reps' Doctor Visits Through March 13
March 4, 2020
- GE Healthcare Completes Takeover of Japan Licenses for 4 Imaging Agents from Daiichi Sankyo
March 4, 2020
- Kaken’s Efinaconazole Launched in Hong Kong
March 4, 2020
- Vital-Net to Create 20-Strong Team of “Regenerative Medicine Liaisons”
March 3, 2020
- Takeda’s ALK Drug Alunbrig Earns EU Backing for 1st Line NSCLC
March 3, 2020
- Takeda to Sell Latin American Non-Core Assets to Brazil’s Hypera Pharma
March 3, 2020
- Otsuka to Copromote Novartis’ Approval-Pending Entresto in Japan
March 3, 2020
- Sumitomo Dainippon Invests in Oncology Venture Fund
March 3, 2020
- Fujifilm’s US Subsidiary to Launch New iPS Cell Production Facility
March 3, 2020
